| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Shatavisa Mukherjee, Nikhil Era, Mala Mukherjee, Santanu Kumar Tripath. Leukocytoclastic vasculitis secondary to clozapine. Indian journal of psychiatry. vol 61. issue 1. 2020-02-25. PMID:30745661. |
the present case highlights a report of lcv in a 59-year-old male with a history of paranoid schizophrenia on clozapine therapy. |
2020-02-25 |
2023-08-13 |
Not clear |
| Lavanya P Sharma, Y C Janardhan Redd. Obsessive-compulsive disorder comorbid with schizophrenia and bipolar disorder. Indian journal of psychiatry. vol 61. issue Suppl 1. 2020-02-25. PMID:30745688. |
in addition, certain atypical antipsychotics, clozapine in particular are known to induce or worsen ocs in schizophrenia. |
2020-02-25 |
2023-08-13 |
Not clear |
| Patrick A Stolz, Heidi J Wehring, Fang Liu, Raymond C Love, Marcus Ellis, Bethany A DiPaula, Deanna L Kell. Effects of Cigarette Smoking and Clozapine Treatment on 20-Year All-Cause & Cardiovascular Mortality in Schizophrenia. The Psychiatric quarterly. vol 90. issue 2. 2020-02-24. PMID:30632082. |
effects of cigarette smoking and clozapine treatment on 20-year all-cause & cardiovascular mortality in schizophrenia. |
2020-02-24 |
2023-08-13 |
Not clear |
| Lenise P Francesconi, André T Victorino, Iarsan A Salah, Victor H S Cordova, Eduarda Dias da Rosa, Larissa Oliveira, Raquel V M Jacobus, Paulo S Belmonte-de-Abreu, Keila M Ceresé. Proinflammatory and anti-inflammatory biomarkers in schizophrenia and influence of simvastatin on the interleukin-6. International clinical psychopharmacology. vol 34. issue 2. 2020-02-18. PMID:30461427. |
the present study sought to assess biomarkers of inflammation in stable patients with schizophrenia (sz) on clozapine therapy. |
2020-02-18 |
2023-08-13 |
Not clear |
| Aviv Segev, Anthony Evans, John Hodsoll, Eromona Whiskey, Rebecca S Sheriff, Sukhi Shergill, James H MacCab. Hyoscine for clozapine-induced hypersalivation: a double-blind, randomized, placebo-controlled cross-over trial. International clinical psychopharmacology. vol 34. issue 2. 2020-02-18. PMID:30614850. |
clozapine is the only evidence-based antipsychotic for treatment-resistant schizophrenia. |
2020-02-18 |
2023-08-13 |
Not clear |
| Chi-Shin Wu, Tien-Yu Chen, Shang-Ying Tsai, Chiao-Chicy Chen, Chian-Jue Ku. Estimating the Risk of Pneumonia in Patients With Schizophrenia Newly Receiving Clozapine: A Nationwide Cohort Study. Journal of clinical psychopharmacology. vol 39. issue 4. 2020-02-18. PMID:31188233. |
estimating the risk of pneumonia in patients with schizophrenia newly receiving clozapine: a nationwide cohort study. |
2020-02-18 |
2023-08-13 |
Not clear |
| Chi-Shin Wu, Tien-Yu Chen, Shang-Ying Tsai, Chiao-Chicy Chen, Chian-Jue Ku. Estimating the Risk of Pneumonia in Patients With Schizophrenia Newly Receiving Clozapine: A Nationwide Cohort Study. Journal of clinical psychopharmacology. vol 39. issue 4. 2020-02-18. PMID:31188233. |
we investigated the risk factors of pneumonia in patients with schizophrenia who use clozapine. |
2020-02-18 |
2023-08-13 |
Not clear |
| Marie-Christine Noël, Valerie Powell, Leah Burton, Roshni Panda, Gary Remingto. Clozapine-Related Myocarditis and Rechallenge: A Case Series and Clinical Review. Journal of clinical psychopharmacology. vol 39. issue 4. 2020-02-18. PMID:31205188. |
that clozapine is the only agent with an indication for treatment-resistant schizophrenia presents real challenges if clozapine-related myocarditis (cim) occurs. |
2020-02-18 |
2023-08-13 |
Not clear |
| Man Li, Weiwen Wang, Lan Sun, Wei Du, Hao Zhou, Feng Sha. Chronic clozapine treatment improves the alterations of prepulse inhibition and BDNF mRNA expression in the medial prefrontal cortex that are induced by adolescent social isolation. Behavioural pharmacology. vol 30. issue 4. 2020-02-13. PMID:30157036. |
clozapine, one of the atypical antipsychotics, is widely used in the treatment of schizophrenia patients and in experimental studies. |
2020-02-13 |
2023-08-13 |
rat |
| Guillermo Höni. [Approaches for the treatment of people with schizophrenia that do not respond to clozapine or ultra-resistant schizophrenia. Review of the evidence.] Vertex (Buenos Aires, Argentina). vol XXX. issue 143. 2020-02-10. PMID:31968029. |
[approaches for the treatment of people with schizophrenia that do not respond to clozapine or ultra-resistant schizophrenia. |
2020-02-10 |
2023-08-13 |
Not clear |
| Jayan George, Richard Hotham, William Melton, Keith Chappl. Clozapine-induced stercoral colitis: a surgical perspective. BMJ case reports. vol 12. issue 8. 2020-02-06. PMID:31471354. |
we describe a case of a 46-year-old man with schizophrenia treated with clozapine who presented as an emergency with abdominal pain on the background of a 1 month history of constipation. |
2020-02-06 |
2023-08-13 |
Not clear |
| Nikki Templeton, Bronwyn Kivell, Amy McCaughey-Chapman, Bronwen Connor, Anne Camille La Flamm. Clozapine administration enhanced functional recovery after cuprizone demyelination. PloS one. vol 14. issue 5. 2020-01-15. PMID:31071102. |
the atypical antipsychotic agent, clozapine, is used to treat a variety of neurological disorders including schizophrenia and parkinson's disease and readily crosses the blood brain barrier to interact with a wide range of neuroreceptors including those for dopamine and serotonin. |
2020-01-15 |
2023-08-13 |
mouse |
| Po-Yu Chen, Chun-Hsin Chen, Chin-Kuo Chang, Chung-Feng Kao, Mong-Liang Lu, Shih-Ku Lin, Ming-Chyi Huang, Ling-Ling Hwang, Valeria Mondell. Orexin-A Levels in Relation to the Risk of Metabolic Syndrome in Patients with Schizophrenia Taking Antipsychotics. The international journal of neuropsychopharmacology. vol 22. issue 1. 2019-12-30. PMID:30204875. |
we investigated the association between orexin-a levels and metabolic syndrome in patients with schizophrenia treated with clozapine or less obesogenic antipsychotics compared with nonpsychiatric controls. |
2019-12-30 |
2023-08-13 |
Not clear |
| Alp Ucok, Elif Anıl Yağcıoğlu, Mustafa Yıldız, Semra Ulusoy Kaymak, Meram Can Saka, Rümeysa Taşdelen, Ayşen Esen Danacı, Şevin Hun Şeno. Reasons for clozapine discontinuation in patients with treatment-resistant schizophrenia. Psychiatry research. vol 275. 2019-12-30. PMID:30908979. |
reasons for clozapine discontinuation in patients with treatment-resistant schizophrenia. |
2019-12-30 |
2023-08-13 |
Not clear |
| Alp Ucok, Elif Anıl Yağcıoğlu, Mustafa Yıldız, Semra Ulusoy Kaymak, Meram Can Saka, Rümeysa Taşdelen, Ayşen Esen Danacı, Şevin Hun Şeno. Reasons for clozapine discontinuation in patients with treatment-resistant schizophrenia. Psychiatry research. vol 275. 2019-12-30. PMID:30908979. |
the aim of this retrospective chart-review study was to investigate the causes of clozapine discontinuation in patients with treatment-resistant schizophrenia. |
2019-12-30 |
2023-08-13 |
Not clear |
| Alp Ucok, Elif Anıl Yağcıoğlu, Mustafa Yıldız, Semra Ulusoy Kaymak, Meram Can Saka, Rümeysa Taşdelen, Ayşen Esen Danacı, Şevin Hun Şeno. Reasons for clozapine discontinuation in patients with treatment-resistant schizophrenia. Psychiatry research. vol 275. 2019-12-30. PMID:30908979. |
our findings point out the importance of enhancing psychiatrists' ability to handle manageable side effects to minimize discontinuations and maximize the benefits of clozapine in patients with treatment-resistant schizophrenia. |
2019-12-30 |
2023-08-13 |
Not clear |
| Essam Daod, Amir Krivoy, Gal Shoval, Salman Zubedat, John Lally, Limor Vadas, Abraham Weizman, Alon Reshef, Boaz Bloc. Psychiatrists' attitude towards the use of clozapine in the treatment of refractory schizophrenia: A nationwide survey. Psychiatry research. vol 275. 2019-12-30. PMID:30913436. |
psychiatrists' attitude towards the use of clozapine in the treatment of refractory schizophrenia: a nationwide survey. |
2019-12-30 |
2023-08-13 |
Not clear |
| Antonio F Pardiñas, Mariana Nalmpanti, Andrew J Pocklington, Sophie E Legge, Christopher Medway, Adrian King, John Jansen, Marinka Helthuis, Stanley Zammit, James MacCabe, Michael J Owen, Michael C O'Donovan, James T R Walter. Pharmacogenomic Variants and Drug Interactions Identified Through the Genetic Analysis of Clozapine Metabolism. The American journal of psychiatry. vol 176. issue 6. 2019-12-30. PMID:30922102. |
this study is the first to adopt the framework of genome-wide association studies (gwass) to discover genetic markers of clozapine plasma concentrations in a large sample of patients with treatment-resistant schizophrenia. |
2019-12-30 |
2023-08-13 |
Not clear |
| Andrea Galova, Patricia Berney, Jules Desmeules, Ioannis Sergentanis, Marie Besso. A case report of cholinergic rebound syndrome following abrupt low-dose clozapine discontinuation in a patient with type I bipolar affective disorder. BMC psychiatry. vol 19. issue 1. 2019-12-16. PMID:30782143. |
there have been previous reported cases of cholinergic rebound in the literature; however, these reports described cholinergic rebound following cessation of high doses of clozapine in patients diagnosed with schizophrenia. |
2019-12-16 |
2023-08-13 |
Not clear |
| Tak Youn, Seong Hoon Jeong, Yong Sik Kim, In Won Chun. Long-term clinical efficacy of maintenance electroconvulsive therapy in patients with treatment-resistant schizophrenia on clozapine. Psychiatry research. vol 273. 2019-12-13. PMID:31207863. |
long-term clinical efficacy of maintenance electroconvulsive therapy in patients with treatment-resistant schizophrenia on clozapine. |
2019-12-13 |
2023-08-13 |
Not clear |